|
N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide
|
C561240 |
|
|
Blue rubber bleb nevus syndrome
|
C536240 |
|
|
regulator of G-protein signaling 22, human
|
C561241 |
|
|
Bobble-head doll syndrome
|
C536241 |
|
|
Atg7 protein, rat
|
C561242 |
|
|
Brachymorphism-onychodysplasia-dysphalangism syndrome
|
C536242 |
|
|
acetyl-CoA synthetase acetylase, E coli
|
C561243 |
|
|
Non-lissencephalic cortical dysplasia
|
C536243 |
|
|
NepYR protein, Drosophila
|
C561244 |
|
|
CG40733 protein, Drosophila
|
C561245 |
|
|
Nondystrophic myotonia
|
C536245 |
|
|
5alpha,10beta,13alpha-triacetoxytax-11-ene-2alpha,7beta,9alpha,20-tetraol
|
C561246 |
|
|
Noninsulin-dependent diabetes mellitus with deafness
|
C536246 |
|
|
5alpha,10beta,13beta-triacetoxy-2 alpha,7beta-dihydroxy-2(3-20) abeotaxa-4(20),11-dien-9-one
|
C561247 |
|
|
2alpha,9alpha,10beta-triacetoxy-13alpha(beta-D-glucopyranosyloxy)taxa-4(20),11-dien-5alpha-ol
|
C561248 |
|
|
turpiniside
|
C561249 |
|
|
Cytochrome P-450 CYP2E1 Inducers
|
D065700 |
[Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP2E1.
] |
|
Cytochrome P-450 CYP3A Inducers
|
D065701 |
[Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP3A.
] |
|
Cytochrome P-450 CYP2B6
|
D065702 |
[A cytochrome P450 enzyme subtype that oxidizes a diverse array of XENOBIOTICS. The expression of CYP2B6 varies widely between individuals which is due to the high rate of GENETIC POLYMORPHISMS. Examples of drugs metabolized by CYP2B6 include BUPROPION; efavirenz; CYCLOPHOSPHAMIDE; and MEPERIDINE.
] |
|
Malformations of Cortical Development, Group I
|
D065703 |
[Cortical malformations secondary to abnormal neuronal and glial CELL PROLIFERATION or APOPTOSIS in NEUROGENESIS. This group includes congenital MICROCEPHALIES; MICROLISSENCEPHALIES, megalencephalies, HEMIMEGALENCEPHALIES and cortical dysplasias with balloon cells.
] |
